The National Vaccine Institute (NVI) in Ghana has embarked on a two-month survey to gauge public attitudes towards Made-in-Ghana vaccines, aiming to address vaccine hesitancy and misinformation across the country.

The survey, which covers all 16 regions and 55 districts, will gather insights from 11,077 respondents through structured interviews and seven focus group discussions.

A statement signed by Dr. Sodzi Sodzi-Tettey, CEO of NVI, emphasized the importance of public participation in the survey. "This is not a sales pitch. We genuinely want to listen and understand. The information provided is strictly confidential. Together, we build vaccine confidence that protects every Ghanaian," he said.

The survey seeks to identify drivers of vaccine confidence, examine barriers to acceptance, and map misinformation trends undermining vaccine uptake. According to Dr. Sodzi-Tettey, "Local vaccines must inspire confidence to succeed. Ghana has long been a leader in immunization in West Africa, built on trust in health workers and vaccines. As we begin manufacturing our own vaccines, we must carry that legacy forward through transparency, engagement, and listening to communities."

The survey's nationwide coverage is crucial, as vaccine confidence varies significantly across regions. "Parts of Northern Ghana report higher levels of hesitancy, while urban areas face different misinformation dynamics," Dr. Sodzi-Tettey noted.

The NVI appeals to residents in the selected districts to participate in the survey, which runs from February 16 to March 10, 2026. "The voices of respondents are important. Their feedback, concerns, questions, and experiences will directly shape government communication strategies and ensure that Made-in-Ghana vaccines reach every household," Dr. Sodzi-Tettey urged.

The survey's findings will inform communication strategies, identify trusted messengers, and guide region-specific vaccine messaging, ultimately supporting Ghana's health security transition and building sustained public trust in Made-in-Ghana vaccines.